246 Shares in iShares Biotechnology ETF (NASDAQ:IBB) Bought by Ashton Thomas Securities LLC

Ashton Thomas Securities LLC acquired a new stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 246 shares of the financial services provider’s stock, valued at approximately $36,000.

Other institutional investors have also added to or reduced their stakes in the company. Jane Street Group LLC purchased a new position in shares of iShares Biotechnology ETF during the first quarter valued at about $14,386,000. Cetera Investment Advisers grew its holdings in shares of iShares Biotechnology ETF by 689.4% during the 1st quarter. Cetera Investment Advisers now owns 91,078 shares of the financial services provider’s stock worth $12,498,000 after acquiring an additional 79,541 shares during the period. State of Michigan Retirement System raised its position in shares of iShares Biotechnology ETF by 150.0% in the 2nd quarter. State of Michigan Retirement System now owns 125,000 shares of the financial services provider’s stock worth $17,158,000 after acquiring an additional 75,000 shares in the last quarter. Aristides Capital LLC bought a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $9,180,000. Finally, Sanctuary Advisors LLC purchased a new position in shares of iShares Biotechnology ETF in the 2nd quarter valued at approximately $8,118,000. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Down 0.4 %

Shares of IBB stock opened at $143.80 on Thursday. The business’s fifty day moving average is $144.78 and its 200 day moving average is $141.57. iShares Biotechnology ETF has a twelve month low of $116.70 and a twelve month high of $150.57.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.